Arcadia Biosciences
RKDA
P/S ratio for Arcadia Biosciences (RKDA)
P/S ratio as of April 2024 (TTM): 0.4916
According to Arcadia Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.491609. At the end of 2023 the company had a P/S ratio of 0.6135.
P/S ratio history for Arcadia Biosciences from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6135 | -11.37% |
| 2022 | 0.6922 | -79.66% |
| 2021 | 3.40 | -19.66% |
| 2020 | 4.24 | -89.55% |
| 2019 | 40.5 | 292.02% |
| 2018 | 10.3 | 254.63% |
| 2017 | 2.92 | -77.29% |
| 2016 | 12.8 | -48.26% |
| 2015 | 24.8 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Marrone Bio Innovations
MBII | 3.28 | 568.20% | 🇺🇸 USA |
 Codexis
CDXS | 3.06 | 521.83% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | 1.13 | 129.83% | 🇺🇸 USA |
 American Vanguard AVD | 0.5790 | 17.78% | 🇺🇸 USA |